{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:55:38Z","timestamp":1790650538398,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The European and Developing Countries Clinical Trials Partnership (EDCTP2) programme supported by the European Union","award":["TMA.2017.GSF.1942-TB-DM"],"award-info":[{"award-number":["TMA.2017.GSF.1942-TB-DM"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Type-2 diabetes mellitus (DM) increases tuberculosis (TB) risk and can worsen treatment outcomes. Both diseases and their treatments induce significant metabolic and biochemical perturbations that influence disease progression and management. This study longitudinally evaluated clinical, metabolic, and serum biochemical changes in patients with pulmonary TB with and without DM before and during anti-TB therapy. Ninety-five adult patients newly diagnosed with pulmonary TB in Ghana were stratified into TB-Only (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200949; HbA1c\u2009&lt;\u20096.5%) and TB-DM (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200946; HbA1c\u2009\u2265\u20096.5%) groups, including treated (TB-DMt) and untreated (TB-DMnt) diabetes subgroups. Serum samples collected at baseline (t\n                    <jats:sub>0<\/jats:sub>\n                    ), day 28 (t\n                    <jats:sub>28<\/jats:sub>\n                    ), and day 56 (t\n                    <jats:sub>56<\/jats:sub>\n                    ) were analyzed for electrolytes, renal function, liver enzymes, and lipid profiles using validated clinical chemistry analyzer. TB-DM cohorts exhibited significantly lower chloride levels at all time points relative to the TB-Only cohort (e.g., 98 vs. 100 mmol\/L at t\n                    <jats:sub>0<\/jats:sub>\n                    ,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). Hyponatremia (serum sodium\u2009&lt;\u2009136 mmol\/L) was prevalent during the intensive anti-TB treatment phase, affecting 53.1% of TB-Only patients, 61.1% of TB-DMt patients, and 70.0% of TB-DMnt patients. Liver function tests revealed elevated bilirubin, gamma-glutamyl transferase (g-GT), alkaline phosphatase (ALP), and alanine aminotransferase (ALT) levels, particularly in TB-DMnt patients, with normalization over time. Lipid profiles showed a pro-atherogenic pattern with elevated triglycerides and total cholesterol (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05). High-density and low-density lipoproteins were increased at select time points. Positive correlations were noted among albumin, cholesterol fractions, and electrolytes. Primary microbiological treatment outcomes, including sputum conversion and completion rates, were similar regardless of diabetic status. The distinctive metabolic and biochemical derangements in TB-DM, especially untreated diabetes, highlight the importance of integrated clinical management. Elevated hepatic enzymes in TB-DMnt may delay metformin initiation, suggesting a need to optimize timing post hepatic recovery, while the prevalence of hyponatremia underscores the need for routine electrolyte monitoring in TB patients with diabetes. The dysregulated lipid profile highlights cardiovascular risk that warrants routine monitoring. Despite metabolic challenges, effective TB treatment outcomes are achievable with comprehensive care.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-36529-8","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T09:33:25Z","timestamp":1770197605000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Patients with tuberculosis and diabetes show altered clinical and biochemical parameters during anti-TB treatment"],"prefix":"10.1038","volume":"16","author":[{"given":"Augustine Boadu","family":"Asare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prince","family":"Asare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Yeboah-Manu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Osei-Wusu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emelia Danso","family":"Konadu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adwoa","family":"Asante-Poku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayra","family":"Klinogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Adjei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desmond Omane","family":"Acheampong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane S.","family":"Afriyie-Mensah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atiase","family":"Yacoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy","family":"Yeboah-Manu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"36529_CR1","unstructured":"International Diabetes Federation. IDF Diabetes Atlas, 11th ed. https:\/\/diabetesatlas.org\/media\/uploads\/sites\/3\/2025\/04\/IDF_Atlas_11th_Edition_2025.pdf (International Diabetes Federation, 2025)."},{"key":"36529_CR2","unstructured":"World Health Organization. Diabetes Fact Sheet. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/diabetes (World Health Organization, 2024)."},{"issue":"7","key":"36529_CR3","doi-asserted-by":"publisher","first-page":"783","DOI":"10.5588\/ijtld.18.0433","volume":"23","author":"P Huangfu","year":"2019","unstructured":"Huangfu, P., Ugarte-Gil, C., Golub, J., Pearson, F. & Critchley, J. The effects of diabetes on tuberculosis treatment outcomes: an updated systematic review and meta-analysis. Int. J. Tuberc. Lung Dis. 23(7), 783\u2013796 (2019).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"36529_CR4","doi-asserted-by":"publisher","first-page":"e53948","DOI":"10.2196\/53948","volume":"10","author":"L Zhao","year":"2024","unstructured":"Zhao, L., Gao, F., Zheng, C. & Sun, X. The impact of optimal glycemic control on tuberculosis treatment outcomes in patients with diabetes mellitus: systematic review and meta-analysis. JMIR public. Health Surveillance. 10, e53948 (2024).","journal-title":"JMIR public. Health Surveillance"},{"key":"36529_CR5","unstructured":"World Health Organization. Global Tuberculosis Report 2025. https:\/\/www.who.int\/publications\/i\/item\/9789240101531  (World Health Organization, 2025)."},{"issue":"10","key":"36529_CR6","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.tim.2020.04.010","volume":"28","author":"NC Howard","year":"2020","unstructured":"Howard, N. C. & Khader, S. A. Immunometabolism during Mycobacterium tuberculosis infection. Trends Microbiol. 28(10), 832\u2013850 (2020).","journal-title":"Trends Microbiol."},{"key":"36529_CR7","doi-asserted-by":"publisher","first-page":"204993612210958","DOI":"10.1177\/20499361221095831","volume":"9","author":"G C\u00e1ceres","year":"2022","unstructured":"C\u00e1ceres, G., Calderon, R. & Ugarte-Gil, C. Tuberculosis and comorbidities: treatment challenges in patients with comorbid diabetes mellitus and depression. Ther. Adv. Infect. Dis. 9, 20499361221095831. https:\/\/doi.org\/10.1177\/20499361221095831 (2022).","journal-title":"Ther. Adv. Infect. Dis."},{"issue":"333","key":"36529_CR8","first-page":"2161","volume":"6","author":"LF Sama","year":"2017","unstructured":"Sama, L. F. et al. Liver dysfunction in TB-diabetic and TB non-diabetic patients admitted in TB referral hospital in Western Cameroon. Biochem. Anal. Biochem. 6(333), 2161\u20131009 (2017).","journal-title":"Biochem. Anal. Biochem."},{"issue":"1","key":"36529_CR9","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s12879-019-4010-7","volume":"19","author":"N Saito","year":"2019","unstructured":"Saito, N. et al. Impact of renal function-based anti-tuberculosis drug dosage adjustment on efficacy and safety outcomes in pulmonary tuberculosis complicated with chronic kidney disease. BMC Infect. Dis. 19(1), 374. https:\/\/doi.org\/10.1186\/s12879-019-4010-7 (2019).","journal-title":"BMC Infect. Dis."},{"issue":"14","key":"36529_CR10","doi-asserted-by":"publisher","first-page":"4843","DOI":"10.3390\/jcm12144843","volume":"12","author":"ACDS Sales","year":"2023","unstructured":"Sales, A. C. D. S. et al. Clinical features, biochemical parameters, and treatment adherence of individuals who started the treatment for active pulmonary tuberculosis during the pandemic period. J. Clin. Med. 12(14), 4843 (2023).","journal-title":"J. Clin. Med."},{"key":"36529_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz284","author":"C Ugarte-Gil","year":"2019","unstructured":"Ugarte-Gil, C. et al. Diabetes mellitus among pulmonary tuberculosis patients from 4 tuberculosis-endemic countries: the tandem study. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciz284 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"36529_CR12","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ebiom.2018.05.011","volume":"32","author":"F Vrieling","year":"2018","unstructured":"Vrieling, F. et al. Patients with concurrent tuberculosis and diabetes have a pro-atherogenic plasma lipid profile. EBioMedicine 32, 192\u2013200 (2018).","journal-title":"EBioMedicine"},{"issue":"1","key":"36529_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-020-4843-0","volume":"20","author":"NN Barreda","year":"2020","unstructured":"Barreda, N. N. et al. Severe pulmonary radiological manifestations are associated with a distinct biochemical profile in blood of tuberculosis patients with dysglycemia. BMC Infect. Dis. 20(1), 1\u201314 (2020).","journal-title":"BMC Infect. Dis."},{"key":"36529_CR14","unstructured":"World Health Organization. Definitions and reporting framework for tuberculosis\u20132013 revision: updated December 2014 and January 2020. In Definitions and reporting framework for tuberculosis\u20132013 revision: updated December 2014 and January 2020 2013."},{"issue":"12","key":"36529_CR15","doi-asserted-by":"publisher","first-page":"5875","DOI":"10.1128\/JCM.42.12.5875-5876.2004","volume":"42","author":"D Yeboah-Manu","year":"2004","unstructured":"Yeboah-Manu, D. et al. Evaluation of decontamination methods and growth media for primary isolation of Mycobacterium ulcerans from surgical specimens. J. Clin. Microbiol. 42(12), 5875\u20135876 (2004).","journal-title":"J. Clin. Microbiol."},{"key":"36529_CR16","unstructured":"Ghana Health Service. Guidelines for Clinical Management of Tuberculosis and HIV Co-Infection in Ghana. https:\/\/www.moh.gov.gh\/wp-content\/uploads\/2016\/02\/GHS-TB-HIV-Clinical-Mgmt-Guidelines.pdf (2016)."},{"issue":"3","key":"36529_CR17","doi-asserted-by":"publisher","first-page":"232","DOI":"10.4103\/lungindia.lungindia_111_19","volume":"37","author":"DJ Christopher","year":"2020","unstructured":"Christopher, D. J. et al. Burden of diabetes among patients with tuberculosis: 10-year experience from a tertiary care referral teaching hospital in South India. Lung India. 37(3), 232\u2013237 (2020).","journal-title":"Lung India"},{"key":"36529_CR18","doi-asserted-by":"publisher","first-page":"696517","DOI":"10.3389\/fcvm.2021.696517","volume":"8","author":"V Chidambaram","year":"2021","unstructured":"Chidambaram, V. et al. Higher serum cholesterol levels are associated with reduced systemic inflammation and mortality during tuberculosis treatment independent of body mass index. Front. Cardiovasc. Med. 8, 696517 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"36529_CR19","doi-asserted-by":"publisher","first-page":"1721727X2513517","DOI":"10.1177\/1721727X251351772","volume":"23","author":"I Javid","year":"2025","unstructured":"Javid, I. et al. Biochemical profiling of tuberculosis patients and the impact of co-infection and comorbidities. Eur. J. Inflamm. 23, 1721727X251351772 (2025).","journal-title":"Eur. J. Inflamm."},{"issue":"1","key":"36529_CR20","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1186\/s12879-020-05473-x","volume":"20","author":"A Mily","year":"2020","unstructured":"Mily, A. et al. Slow radiological improvement and persistent low-grade inflammation after chemotherapy in tuberculosis patients with type 2 diabetes. BMC Infect. Dis. 20(1), 933 (2020).","journal-title":"BMC Infect. Dis."},{"issue":"12","key":"36529_CR21","doi-asserted-by":"publisher","first-page":"e0295556","DOI":"10.1371\/journal.pone.0295556","volume":"18","author":"SH Kwak","year":"2023","unstructured":"Kwak, S. H. et al. Association between diabetes mellitus and cause of death in patients with tuberculosis: A Korean nationwide cohort study. PloS One. 18(12), e0295556 (2023).","journal-title":"PloS One"},{"issue":"7","key":"36529_CR22","doi-asserted-by":"publisher","first-page":"101666","DOI":"10.1016\/j.cpcardiol.2023.101666","volume":"48","author":"M Shabil","year":"2023","unstructured":"Shabil, M. et al. Cardiovascular manifestation in tuberculosis cases: a systematic review and meta-analysis. Curr. Probl. Cardiol. 48(7), 101666 (2023).","journal-title":"Curr. Probl. Cardiol."},{"issue":"1","key":"36529_CR23","doi-asserted-by":"publisher","first-page":"16254","DOI":"10.1038\/s41598-021-95704-1","volume":"11","author":"YS Jo","year":"2021","unstructured":"Jo, Y. S. et al. Relationship between total cholesterol level and tuberculosis risk in a nationwide longitudinal cohort. Sci. Rep. 11(1), 16254 (2021).","journal-title":"Sci. Rep."},{"issue":"3","key":"36529_CR24","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3390\/medicina61030365","volume":"61","author":"K Kubalov\u00e1","year":"2025","unstructured":"Kubalov\u00e1, K. et al. Lipid levels and atherogenic indices as important predictive parameters in the assessment of cardiovascular risk in patients with pulmonary Tuberculosis\u2014Slovak pilot study. Medicina 61(3), 365 (2025).","journal-title":"Medicina"},{"issue":"1","key":"36529_CR25","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12879-021-05929-8","volume":"21","author":"W Xiao","year":"2021","unstructured":"Xiao, W. et al. Delayed diagnosis of tuberculosis in patients with diabetes mellitus co-morbidity and its associated factors in Zhejiang Province, China. BMC Infect. Dis. 21(1), 272 (2021).","journal-title":"BMC Infect. Dis."},{"issue":"9","key":"36529_CR26","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1111\/dom.14766","volume":"24","author":"S Ryang","year":"2022","unstructured":"Ryang, S. et al. A double\u2010blind, randomized controlled trial on glucose\u2010lowering effects and safety of adding 0.25 or 0.5\u00a0mg lobeglitazone in type 2 diabetes patients with inadequate control on metformin and dipeptidyl peptidase\u20104 inhibitor therapy: REFIND study. Diabetes Obes. Metabolism. 24(9), 1800\u20131809 (2022).","journal-title":"Diabetes Obes. Metabolism"},{"key":"36529_CR27","doi-asserted-by":"crossref","unstructured":"Gautam, J. K., Thanvi, A., Soni, P. & Anand, P. K. Estimation of the proportion and determinants of diabetes mellitus among notified tuberculosis patients in Jaipur, Rajasthan, India. Cureus. 17(3) (2025).","DOI":"10.7759\/cureus.80319"},{"issue":"1","key":"36529_CR28","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1186\/s12879-023-08386-7","volume":"23","author":"Q Yang","year":"2023","unstructured":"Yang, Q. et al. Computed tomography findings in patients with pulmonary tuberculosis and diabetes at an infectious disease hospital in China: a retrospective cross-sectional study. BMC Infect. Dis. 23(1), 436 (2023).","journal-title":"BMC Infect. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36529-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36529-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36529-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T11:14:53Z","timestamp":1771586093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36529-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["36529"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-36529-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7266"}}